Recent Posts

• Biologics by McKesson is now the Exclusive Specialty Pharmacy Provider of XERMELO (telotristat ethyl), an FDA Approved Therapy for Carcinoid Syndrome Diarrhea
• VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson
• PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson
• TARPEYO (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson
• Carcinoid Cancer Foundation Q&A